Navigation Links
Hormone Therapy applicable for Prostate Cancer

Researchers made a new study which suggests hormone suppression therapy could increase substantially an advanced prostate cancer patient's chances of living free of the disease.Michel Bolla, a professor at Grenoble University Hospital, examined the potential benefits of suppressing the male hormone androgen, similar to the more commonly known male hormone testosterone, among 400 patients in advanced stages// of their prostate cancer, meaning their chances of survival were deteriorating. The international study involved patients throughout Europe as well as in Canada and Israel.

In the study, the men were randomly assigned to receive either radiation therapy alone or androgen suppression given during and after radiotherapy for three years. The average follow-up period was five and a half years.

Study results revealed almost three-quarters of the men who received the combination therapy, or 70 percent, had an increased five-year, disease-free survival rate compared to only 30 percent of patients who received only radiotherapy. Overall, survival rates were 80 percent within the hormone-suppression group and 62 percent for the radiotherapy group.

Bolla felt that at the present time a long-term hormone therapy 2 or 3 years compared to short-term resulted in statistically significant improvements in overall survival, as shown by this trial. The long-term survival rate for men with aggressive prostate cancer is poor, so additional therapies are needed to improve their chances. He added the findings also indicate hormone suppression with radiotherapy or external irradiation could trigger apoptosis -- the cancer cells destroying themselves.

However, there were side effects, Bolla said, including hot flashes, loss of libido and impotency. Kenneth Koeneman, urology professor at University of Texas Southwestern Medical Center at Dallas, said the side effects go beyond sexual dysfunction. "It's systemic castration," Koeneman told UPI
'"/>




Page: 1 2

Related medicine news :

1. Levothyroxine Thyroid Hormone Replacement, Approved for Hypothyroidism
2. Hormone replacement Therapy a headache
3. Ovarian cancer in relationship with Hormone therapy
4. Hormone contraceptives lead to bone problems
5. Hormone treatment helps obese people slim down
6. Hormone Deficiency Results In Miscarriage
7. Hormones Linked To Migraines
8. Hormone replacement therapy helps women
9. Decrease of Hunger Hormone after Obesity Surgery
10. Possible benefits of Hormone Replacement Therapy
11. Hormone replacement therapy improves sexual function
Post Your Comments:
(Date:7/3/2009)...if. The newest revolution in microbiology testing ...ir sheep, a less-hirsute version of the familiar w...ford University School of Medicine, which is to be...ly are these ruminants low-maintenance and parasit... the microbiology tests necessary to diagnose infe...
(Date:7/3/2009)...may thwart treatment-resistant strain, study finds... -- Extreme drug-resistant tuberculosis might some...Parkinson,s disease, suggests a new study. , ...California, San Diego, report in the July 3 issue ...available entacapone and tolcapone have the potent...
(Date:7/3/2009)...uly 3 Republicans on th...e in health care reform legislation that would eli...pens, many women could lose coverage for abortion ...cludes. Plus, millions of uninsured women will sti... been promised a better quality of life. , , If...
(Date:7/3/2009)... Two companies and three individuals have ...n annual international competition designed to rew...,000-member SafetyXChange.org community released i...009 at http://www.safetyxchange.org/saxcies-video...tions who dedicate their lives to keeping others s...
Breaking Medicine News(10 mins):Health News:Rare sheep could be key to better diagnostic tests in developing world, says Stanford study 2Health News:Rare sheep could be key to better diagnostic tests in developing world, says Stanford study 3Health News:New Weapons in Fight Against TB? 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 2Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 3Health News:Excellence in Workplace Safety Recognized as 2009 Saxcies Award Winners Named 4
... detectable level of prostate-specific antigen (PS...ncer after radical// prostatectomy. In a new May...DT) is found to be a reliable tool to distinguish ...s PSA levels after therapy from those who are at g...
...rug abuse is increasing at an alarming rate in Aus...young as 14 are turning to drugs and at least one ...cording to Statistics on Drug Use in Australia 200...nstitute of Health and Welfare. According to the...
...ertility declining among men of north India. And t... the All India Institute of Medical Sciences// (AI...medical institution actually reveals a dramatic fa...y. The sperm count of a normal adult male in Indi...
...MA President, Dr Mukesh Haikerwal, said today that...n population must be the priority of any health re...tralian Governments (COAG) meeting. Dr Haikerwal ...s if the State and Territory Governments do the ri...
Other Medicine News:Health News:Alarming Rise of Methamphetamine Use Among Australian Youth 2Health News:Denim Lovers Beware, Fertility Could Be in Danger, Says a New Study 2
(Date:7/2/2009)...y 3 ,ThromboGenics NV (E...,BioInvent International (OMXS: BINV) announce tha...t of patients for their Phase II trial of,TB-402....st cohort of 100,patients ahead of schedule. TB-4...being developed for the prevention of deep vein th...
(Date:7/1/2009)...e-FirstCall/ -- The largest study of,the genetics...eral new common,single-letter variants in the seq...f the disease. The study, by a multinational conso...etics (Nasdaq: DCGN ), analyzed the genomes of,m...from fourteen countries.,It is published today in...
(Date:6/30/2009)...In two recent COPD studies sponsored by DEY LP, PA...ra and Ultra II) were used to show that nebulized ...c.) improves pulmonary function. , , "We are p... exclusive nebulizer systems for recent studies co...nd et al. used an open-label crossover design allo...
(Date:6/30/2009)... Therapeutics Inc. today announced the initiation ... with complicated urinary tract infections. CXA-1...in antibiotic with excellent in vitro and in vi...luding drug resistant isolates. Calixa is investi...s bacterial infections in hospitalized patients. ,...
Breaking Medicine Technology:ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 2ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 3ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 4ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402 5deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 2deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 3deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 4deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia 5PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies 2Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections 2WuXi PharmaTech to Acquire AppTec Laboratory Services Inc 2443 1WuXi PharmaTech to Acquire AppTec Laboratory Services Inc 2443 2WuXi PharmaTech to Acquire AppTec Laboratory Services Inc 2443 3WuXi PharmaTech to Acquire AppTec Laboratory Services Inc 2443 4WuXi PharmaTech to Acquire AppTec Laboratory Services Inc 2443 5Pharmos Corporation Announces Board and Management Changes 2440 1Pharmos Corporation Announces Board and Management Changes 2440 2Pharmos Corporation Announces Board and Management Changes 2440 3Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection 1135 1Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection 1135 2Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection 1135 3Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection 1135 4Novel Mechanism for Long Term Learning Identified by Carnegie Mellon Researchers 1133 1Novel Mechanism for Long Term Learning Identified by Carnegie Mellon Researchers 1133 2Novel Mechanism for Long Term Learning Identified by Carnegie Mellon Researchers 1133 3
...wswire/ -- , - Cipralex Better Tolerated and at Le...eck A/S announces new study data published today i..., demonstrating that,Cipralex(R) (escitalopram) wa... patients with major depressive disorder (MDD) and...t(1). The study,directly compared Cipralex(R) (an ...
...CSE: GEN) announced,today pre-clinical data illust...mab) antibody may have broad potential,to treat ca...dermal,growth factor receptor). , Recently, mutati... EGFr have been identified in tumors from lung can...tor in the potential success of,EGFr-directed trea...
Other Medicine Technology:Newly Published Data Demonstrates Superiority of Cipralex Over,Duloxetine for Acute Treatment of Depression 2Newly Published Data Demonstrates Superiority of Cipralex Over,Duloxetine for Acute Treatment of Depression 3Newly Published Data Demonstrates Superiority of Cipralex Over,Duloxetine for Acute Treatment of Depression 4Newly Published Data Demonstrates Superiority of Cipralex Over,Duloxetine for Acute Treatment of Depression 5
Inquire
The Cypress quick test is a rapid immunochromatographic screening test for the detection of antibodies to Trypanosoma cruzi. It can be used with whole blood, serum or plasma. The method employs a un
Sprint Quattro Secure™ is a Steroid-Eluting, True Bipolar, Active Fixation ICD Lead.
The Medtronic Subcutaneous Lead System Model 6996 SQ is implanted subcutaneously with the use of the Medtronic Tunneling Tool Model 6996T. Improved SQ design and implant technique offer low DFTs, a f
Medicine Products: